You are viewing the site in preview mode

Skip to main content

Advertisement

Table 4 Organ in BF group

From: Portfolio of prospective clinical trials including brachytherapy: an analysis of the ClinicalTrials.gov database

BF group Prostate (n = 80, %) Cervix uteri (n = 54, %) Breast (n = 29, %) Uterus (n = 14, %) Others (n = 68, %) p value
Prim. Completion attribute       
 Actual 30 (37.5 %) 18 (33.3 %) 13 (44.8 %) 3 (21.4 %) 18 (26.5 %) 0.283a
 Anticipated 43 (53.8 %) 29 (53.7 %) 15 (51.7 %) 9 (64.3 %) 36 (52.9 %
 None 7 (8.8 %) 7 (13.0 %) 1 (3.4 %) 2 (14.3 %) 14 (20.6 %)
Completion date attribute       
 Actual 26 (32.5 %) 12 (22.2 %) 8 (27.6 %) 3 (21.4 %) 20 (29.4 %) 0.112a
 Anticipated 39 (48.8 %) 19 (35.2 %) 15 (51.7 %) 5 (35.7 %) 24 (35.3 %)
 None 15 (18.8 %) 23 (42.6 %) 6 (20.7 %) 6 (42.9 %) 24 (35.3 %)
First received       
 1999–2004 12 (15.0 %) 11 (20.4 %) 1 (3.4 %) 1 (7.1 %) 19 (27.9 %) <0.001a
 2005–2009 29 (36.2 %) 19 (35.2 %) 19 (65.5 %) 10 (71.4 %) 20 (29.4 %)
 2010–2015 39 (48.8 %) 24 (44.4 %) 9 (31.0 %) 3 (21.4 %) 29 (42.6 %)
Last changed       
 2005–2009 4 (5.0 %) 4 (7.4 %) 2 (6.9 %) 0 12 (17.6 %) 0.202a
 2010–2015 76 (95.0 %) 50 (92.6 %) 27 (93.1 %) 14 (100 %) 56 (82.4 %)
Primary completion       
 2000–2004 4 (5.5 %) 0 1 (3.6 %) 0 7 (13.0 %) 0.104a
 2005–2009 10 (13.7 %) 10 (21.3 %) 6 (21.4 %) 0 6 (11.1 %)
 2010–2015 36 (49.3 %) 27 (57.4 %) 17 (60.7 %) 8 (66.7 %) 28 (51.9 %)
 2016+ 23 (31.5 %) 10 (21.3 %) 4 (14.3 %) 4 (33.3 %) 13 (24.1 %)
Completion year       
 2000–2004 2 (3.0 %) 0 0 0 6 (13.0 %) 0.027a
 2005–2009 9 (13.6 %) 9 (27.3 %) 2 (8.3 %) 1 (12.5 %) 9 (19.6 %)
 2010–2015 31 (47.0 %) 16 (48.5 %) 11 (45.8 %) 5 (62.5 %) 17 (37.0 %)
 2016+ 24 (36.4 %) 8 (24.2 %) 11 (45.8 %) 2 (25.0 %) 14 (30.4 %)
  1. aChi square test